急诊科阿片类药物过量患者中涉及赛拉嗪的多中心研究
该多中心前瞻性队列纳入2020年9月21日至2021年8月17日美国九家急诊科的成人阿片类药物过量患者,经液相色谱四极杆飞行时间质谱检测血清中的非法阿片类、新型合成阿片类、赛拉嗪及掺杂物。321例符合纳入标准,其中90例赛拉嗪阳性、231例阴性。主要结局心脏骤停需心肺复苏发生在37例,次要结局到达后4小时内昏迷发生在111例。多因素回归分析显示,赛拉嗪阳性者心脏骤停的调整OR为0.30(95%CI 0.10-0.92),昏迷的调整OR为0.52(95%CI 0.29-0.94),均显著更低。
要点
- 急诊阿片类药物过量患者中,赛拉嗪阳性者心脏骤停的调整OR为0.30(95%CI 0.10-0.92),显著低于阴性者。
- 赛拉嗪阳性者到达后4小时内昏迷的调整OR为0.52(95%CI 0.29-0.94),显著低于阴性者。
- 321例中90例赛拉嗪阳性、231例阴性;心脏骤停37例,昏迷111例。
- 研究为九家美国急诊科的多中心前瞻性队列,纳入2020年9月21日至2021年8月17日。
- 血清经液相色谱四极杆飞行时间质谱检测非法阿片类、新型合成阿片类、赛拉嗪及掺杂物。
适用人群与场景
- 美国九家急诊科就诊的成人阿片类药物过量患者,纳入条件为检测阳性 for 非法阿片类(海洛因、芬太尼、芬太尼类似物或新型合成阿片类)或赛拉嗪。
研究设计与关键结果
- 多中心前瞻性队列研究,纳入2020年9月21日至2021年8月17日美国九家急诊科的成人阿片类药物过量患者,共321例符合纳入标准,其中90例赛拉嗪阳性、231例阴性。
- 主要结局为需心肺复苏的心脏骤停,发生在37例;次要结局为到达后4小时内昏迷,发生在111例。
- 多因素回归分析显示,赛拉嗪阳性者心脏骤停的调整OR为0.30(95%CI 0.10-0.92),昏迷的调整OR为0.52(95%CI 0.29-0.94),均显著低于阴性者。
证据类型、等级与局限
- 证据类型:多中心前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,在急诊科非法阿片类药物过量患者中,赛拉嗪阳性者心脏骤停和昏迷的严重程度显著更低。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Illicit opioids, consisting largely of fentanyl, novel synthetic opioids, and adulterants, are the primary cause of drug overdose fatality in the United States. Xylazine, an alpha-2 adrenergic agonist and veterinary tranquilizer, is being increasingly detected among decedents following illicit opioid overdose. Clinical outcomes in non-fatal overdose involving xylazine are unexplored. Therefore, among emergency department patients with illicit opioid overdose, we evaluated clinical outcome differences for patients with and without xylazine exposures.
METHODS: This multicenter, prospective cohort study enrolled adult patients with opioid overdose who presented to one of nine United States emergency departments between 21 September 2020, and 17 August 2021. Patients with opioid overdose were screened and included if they tested positive for an illicit opioid (heroin, fentanyl, fentanyl analog, or novel synthetic opioid) or xylazine. Patient serum was analyzed via liquid chromatography quadrupole time-of-flight mass spectroscopy to detect current illicit opioids, novel synthetic opioids, xylazine and adulterants. Overdose severity surrogate outcomes were: (a) cardiac arrest requiring cardiopulmonary resuscitation (primary); and (b) coma within 4 h of arrival (secondary).
RESULTS: Three hundred and twenty-one patients met inclusion criteria: 90 tested positive for xylazine and 231 were negative. The primary outcome occurred in 37 patients, and the secondary outcome occurred in 111 patients. Using multivariable regression analysis, patients positive for xylazine had significantly lower adjusted odds of cardiac arrest (adjusted OR 0.30, 95% CI 0.10-0.92) and coma (adjusted OR 0.52, 95% CI 0.29-0.94).
CONCLUSIONS: In this large multicenter cohort, cardiac arrest and coma in emergency department patients with illicit opioid overdose were significantly less severe in those testing positive for xylazine.
参考来源
- Love JS, Levine M, Aldy K, et al. Opioid overdoses involving xylazine in emergency department patients: a multicenter study. Clin Toxicol (Phila). 2023. PMID: 37014353. doi:10.1080/15563650.2022.2159427
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。